HFA 2025 Archives - Medical Conferences

Home > Cardiology > HFA 2025

Heart Failure Association
17–20 May 2025
Belgrade, Serbia

Featured articles

HFA 2025 Highlights Podcast

Presented By

Dr. Rachel Giles, Robert van den Heuvel, Medicom

Conference

HFA 2025

4 June 2025 10:59

FINEARTS-HF confirms: indefinite need for HF medication for optimal outcomes

Presented By

Dr Muthiah Vaduganathan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

HFA 2025

Type

News article

20 May 2025 10:25

Online First

REDICAE: Diuretics withdrawal appears feasible in stable HFrEF

Presented By

Dr Jesus Torres Zamudio, Reina Sofia University Hospital Cordoba, Spain

Trial

Phase 2, REDICAE

Conference

HFA 2025

Type

News article

22 May 2025 13:54

PREFER-HF: Is iron therapy helpful in HFpEF with iron deficiency?

Presented By

Dr José Morales-Rull, University Hospital Arnau de Vilanova, Spain

Trial

Phase 3, PREFER-HF

Conference

HFA 2025

Type

News article

22 May 2025 13:53

New gene therapy for HFrEF passes phase 1 testing

Presented By

Dr Roger Hajjar, Mass General Brigham, MA, USA

Trial

Phase 1, NAN-CS101

Conference

HFA 2025

Type

News article

22 May 2025 13:51

MUSIC-HFpEF: Encouraging first results of novel gene therapy for HFpEF

Presented By

Dr Marat Fudim, Duke University, NC, USA

Trial

Phase 1/2, MUSIC-HFpEF

Conference

HFA 2025

Type

News article

22 May 2025 13:50

FIVE-STAR: Mechanistic effects of finerenone in T2D plus CKD unravelled

Presented By

Prof. Atsushi Tanaka, Saga University, Japan

Trial

Phase 4, FIVE-STAR

Conference

HFA 2025

Type

News article

22 May 2025 13:48

High vs low positive end-expiratory pressure in IMV may impact survival

Presented By

Dr Min-Seok Kim, Asan Medical Centre, South Korea

Trial

HELP-AHF

Conference

HFA 2025

Type

News article

21 May 2025 10:55

Consistent results for nexiguran ziclumeran across wildtype and variant ATTR-CM

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 1

Conference

HFA 2025

Type

News article

21 May 2025 10:52

Promising results for novel HCM therapy

Presented By

Dr Anjali Owens, University of Pennsylvania, PA, USA

Trial

Phase 2, CIRRUS-HCM

Conference

HFA 2025

Type

News article

21 May 2025 10:47

SEQUOIA-HCM: Aficamten safe and efficacious for HCM across the globe

Presented By

Dr Caroline Coats, University of Glasgow, UK

Trial

Phase 3, SEQUOIA-HCM

Conference

HFA 2025

Type

News article

21 May 2025 10:45

GLADIATOR: Anti-ulcer agent geranylgeranylacetone explored in HFpEF

Presented By

Dr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

Phase 2, GLADIATOR

Conference

HFA 2025

Type

News article

21 May 2025 10:42

FUTURE-HF: Novel IVC sensor may help control volume and improve function outcomes

Presented By

Dr Kevin Damman, University Medical Center Groningen, the Netherlands

Trial

FUTURE-HF

Conference

HFA 2025

Type

News article

20 May 2025 10:27

FINEARTS-HF confirms: indefinite need for HF medication for optimal outcomes

Presented By

Dr Muthiah Vaduganathan, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

HFA 2025

Type

News article

20 May 2025 10:25

PRAISE-HFrEF: Is it safe to use GLP1-receptor agonists in clinically severe HF?

Presented By

Dr Varun Sundaram, University Hospitals Harrington Heart & Vascular Institute Cleveland, OH, USA

Trial

PRAISE-HFrEF

Conference

HFA 2025

Type

News article

20 May 2025 10:22

HELIOS-B: Health benefits of vutrisiran for ATTR-CM may increase over time

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 3, HELIOS-B

Conference

HFA 2025

Type

News article

20 May 2025 10:21

SOGALDI-PEF: SGLT2 inhibitor plus MRA improves outcomes in HFp/mrEF

Presented By

Dr Joao Ferreira, University of Porto, Portugal

Trial

Phase 2, SOGALDI-PEF

Conference

HFA 2025

Type

News article

20 May 2025 10:19

Featured articles

CONTENTS

Online First